MARA CATE: Open Payments
NPI 1790222867 · FREDERICKSBRG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,684 in 77 payments from 18 companies in 2025. Trend: 2023 $1,834 · 2024 $2,996 · 2025 $1,684
Food & beverage: $1,684
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $307 |
| Janssen Biotech, Inc. | 12 | $238 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $169 |
| QOL Medical, LLC | 7 | $162 |
| Gilead Sciences, Inc. | 4 | $83 |
| Ipsen Biopharmaceuticals, Inc | 3 | $79 |
| Madrigal Pharmaceuticals | 3 | $75 |
| Lilly USA, LLC | 3 | $53 |
| PFIZER INC. | 2 | $52 |
Products named: TREMFYA, XIFAXAN, Sucraid, Linzess, ENTYVIO, IQIRVO, REZDIFFRA, EOHILIA.
Industry payments across VA — which companies pay providers there.
